A phalanx of French biotechs rolled into New York this week for a meeting with life science investors. Among the 20 biotechs at the flesh-pressing festival were some laying the groundwork for IPOs on Nasdaq, including Eli Lilly-partnered diabetes player Adocia.

…read more

Source: French biotech CEOs roll into New York with money on their minds


0 No comments